Connecticut et al v. Teva Pharmaceuticals USA, Inc.

  1. June 22, 2021

    Teva Settles Mississippi Drug Price-Fix Claims For $925K

    Teva Pharmaceuticals USA Inc. has agreed to shell out $925,000 to the state of Mississippi to resolve claims in Pennsylvania federal court that the drug giant and subsidiary Actavis Holdco US Inc. conspired with others to fix the prices of generic medicines, a company spokesperson told Law360 Tuesday.

  2. May 14, 2021

    AGs Say High Court Ruling Doesn't Weaken Drug Price Claims

    State attorneys general on Friday blasted a bid by generic-drug makers to use a recent U.S. Supreme Court ruling as a shield against the prosecutors' price-fixing claims, telling a Pennsylvania federal court that the justices' decision doesn't address the relevant law.

  3. May 06, 2021

    Generic Drug Cos. Invoke FTC Restitution Limits Against AGs

    The potential influence of the U.S. Supreme Court decision striking down the Federal Trade Commission's claimed authority to recover ill-gotten gains in federal court continues to spread, with generic-drug makers citing the ruling Wednesday to fight state attorneys general's price-fixing claims in sprawling Pennsylvania federal court litigation.  

  4. November 03, 2020

    Generics Cos. Attack 'Serial' Complaints In Price-Fixing Row

    Generic drug companies and their executives launched a multipronged attack Monday on one of three complaints filed by state attorneys general amid sprawling multidistrict litigation alleging an industrywide price-fixing conspiracy, arguing it was likely meant as an end-run around limits on amending the other complaints.

  5. June 10, 2020

    AGs Pile On Generics Cos. With 3rd Price-Fixing Complaint

    State enforcers added more treatments to their price-fixing case against generic-drug makers with a third complaint Wednesday in Connecticut federal court accusing 26 companies and 10 individuals of "rampant" collusion on topically applied treatments.

  6. March 02, 2020

    AGs Claim Ample Evidence In Generic Drug Price-Fixing Suit

    A generic-drug maker should face price-fixing allegations by 44 states, two state attorneys general told a Pennsylvania federal judge, saying there's ample evidence the company joined in a conspiracy with Teva.

  7. February 21, 2020

    Teva Floated As Bellwether In Generic Drug Price-Fixing MDL

    A case brought by 44 state attorneys general against Teva Pharmaceuticals and several other drugmakers should be the bellwether for a massive multidistrict litigation over alleged conspiracies to fix the prices of generic drugs, according to a special master's report Thursday.

  8. February 18, 2020

    Former Teva Exec Calls AGs' Price-Fixing Claims 'Threadbare'

    A former Teva executive has urged a Pennsylvania federal judge to toss price-fixing accusations against her from a coalition of 44 state attorneys general as part of multidistrict litigation alleging industrywide price-fixing by generic-drug makers, blasting the claims as "threadbare."

  9. January 29, 2020

    State AGs Diss Pfizer's Effort To Flee Price-Fixing MDL

    A coalition of state attorneys general is bashing Pfizer's attempt to exit multidistrict litigation alleging industrywide price-fixing by generic-drug makers, asserting that Pfizer must be held accountable for its generic-drug subsidiary's alleged involvement in the scheme because the companies are "one and the same."

  10. December 02, 2019

    Pfizer Claims No Link To Generic-Drug Price-Fix Plot

    Pfizer Inc. is seeking to exit the sweeping Pennsylvania multidistrict litigation alleging it conspired with other major drugmakers to keep generic prices high, as the branded drugmaker said its only ties to the allegations stem from a subsidiary, and that's not enough.